Expertise in
6
conditions

Sean S. Wasserman

St George's University Of London, 
London, ENG, GB 
Expertise in
6
conditions
St George's University Of London, 
London, ENG, GB 
OverviewLocationsClinical Research

Overview

Sean Wasserman practices in London, United Kingdom. Mr. Wasserman is highly rated in 6 conditions, according to our data. His top areas of expertise are Tuberculous Meningitis, Bacterial Meningitis, Meningitis, and Pneumocystis Jiroveci Pneumonia.

His clinical research consists of co-authoring 115 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

St George's University Of London, London, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Evaluating Newly Approved Drugs for Multidrug-resistant TB (endTB): A Clinical Trial
Evaluating Newly Approved Drugs for Multidrug-resistant TB (endTB): A Clinical Trial
Enrollment Status: Completed
Publish Date: February 10, 2025
Intervention Type: Drug
Study Drugs: Bedaquiline, Delamanid, Clofazimine, Levofloxacin, Moxifloxacin, Linezolid, Pyrazinamide, MDR-TB regimen
Study Phase: Phase 3
Phase IIA Trial of the Safety and Tolerability of Increased Dose Rifampicin and Adjunctive Linezolid With or Without Aspirin, for HIV-associated Tuberculous Meningitis
Phase IIA Trial of the Safety and Tolerability of Increased Dose Rifampicin and Adjunctive Linezolid With or Without Aspirin, for HIV-associated Tuberculous Meningitis
Enrollment Status: Completed
Publish Date: September 28, 2021
Intervention Type: Drug
Study Drugs: Linezolid, Rifampicin, Aspirin, Standard of Care anti-tuberculous therapy, Dexamethasone
Study Phase: Phase 2
Multi-centre Randomised Controlled Trial of Chloroquine/Hydroxychloroquine Versus Standard of Care for Treatment of Mild Covid-19 in HIV-positive Outpatients in South Africa
Multi-centre Randomised Controlled Trial of Chloroquine/Hydroxychloroquine Versus Standard of Care for Treatment of Mild Covid-19 in HIV-positive Outpatients in South Africa
Enrollment Status: Withdrawn
Publish Date: August 18, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trials

115 Total Publications

Valganciclovir for cytomegalovirus viraemia in advanced HIV disease: a phase 2b randomized placebo-controlled trial of valganciclovir for cytomegalovirus viraemia in adults and adolescents with advanced HIV disease.
Valganciclovir for cytomegalovirus viraemia in advanced HIV disease: a phase 2b randomized placebo-controlled trial of valganciclovir for cytomegalovirus viraemia in adults and adolescents with advanced HIV disease.
Journal: Philosophical transactions of the Royal Society of London. Series B, Biological sciences
Published: November 06, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Wasserman's expertise for a condition
ConditionClose
    View All 13 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile